Compare TEVA & SYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | SYY |
|---|---|---|
| Founded | 1901 | 1969 |
| Country | Israel | United States |
| Employees | 32842 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5B | 34.8B |
| IPO Year | N/A | 2003 |
| Metric | TEVA | SYY |
|---|---|---|
| Price | $31.27 | $74.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $38.63 | ★ $87.38 |
| AVG Volume (30 Days) | 4.8M | ★ 6.1M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.92% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.80 |
| Revenue | N/A | ★ $81,370,000,000.00 |
| Revenue This Year | N/A | $4.84 |
| Revenue Next Year | $3.24 | $4.89 |
| P/E Ratio | ★ $28.19 | $41.11 |
| Revenue Growth | N/A | ★ 3.20 |
| 52 Week Low | $13.04 | $68.00 |
| 52 Week High | $37.35 | $91.85 |
| Indicator | TEVA | SYY |
|---|---|---|
| Relative Strength Index (RSI) | 54.69 | 39.07 |
| Support Level | $30.70 | $72.02 |
| Resistance Level | $31.99 | $77.37 |
| Average True Range (ATR) | 0.88 | 2.19 |
| MACD | 0.33 | 0.21 |
| Stochastic Oscillator | 82.96 | 41.23 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Sysco is the largest US foodservice distributor with 18% share of the highly fragmented $377 billion domestic market. It distributes roughly 500,000 food and nonfood products to restaurants (60% of fiscal 2025 revenue), education and government buildings (8%), healthcare facilities (8%), travel and leisure (7%), and other locations (17%) where individuals consume away-from-home meals. In fiscal 2025, 70% of the firm's revenue was derived from its US foodservice operations, while its international (18%), quick-service logistics (10%), and other (2%) segments contributed the rest.